Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia

被引:476
作者
Orlando, Elena J. [1 ]
Han, Xia [2 ]
Tribouley, Catherine [2 ]
Wood, Patricia A. [2 ]
Leary, Rebecca J. [1 ]
Riester, Markus [1 ]
Levine, John E. [3 ]
Qayed, Muna [4 ]
Grupp, Stephan A. [5 ]
Boyer, Michael [6 ]
De Moerloose, Barbara [7 ]
Nemecek, Eneida R. [8 ]
Bittencourt, Henrique [9 ]
Hiramatsu, Hidefumi [10 ]
Buechner, Jochen [11 ]
Davies, Stella M. [12 ]
Verneris, Michael R. [13 ]
Nguyen, Kevin [14 ]
Brogdon, Jennifer L. [1 ]
Bitter, Hans [1 ]
Morrissey, Michael [1 ]
Pierog, Piotr [2 ]
Pantano, Serafino [15 ]
Engelman, Jeffrey A. [1 ]
Winckler, Wendy [1 ]
机构
[1] Novartis Inst BioMed Res, Cambridge, MA 02139 USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[4] Emory Univ, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA
[5] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[6] Univ Utah, Salt Lake City, UT USA
[7] Ghent Univ Hosp, Dept Pediat Hematol Oncol & Stem Cell Transplanta, Ghent, Belgium
[8] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[9] St Justine Univ, Hlth Ctr, Montreal, PQ, Canada
[10] Kyoto Univ, Dept Pediat, Kyoto, Japan
[11] Oslo Univ Hosp, Dept Pediat Hematol & Oncol, Oslo, Norway
[12] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA
[13] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA
[14] Navigate BioPharma Serv Inc, Carlsbad, CA USA
[15] Novartis Pharma AG, Basel, Switzerland
关键词
DNA-SEQUENCING DATA; T-CELL THERAPY; MUTATIONS; FRAMEWORK; ESCAPE;
D O I
10.1038/s41591-018-0146-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
We identified genetic mutations in CD19 and loss of heterozygosity at the time of CD19(-) relapse to chimeric antigen receptor (CAR) therapy. The mutations are present in the vast majority of resistant tumor cells and are predicted to lead to a truncated protein with a nonfunctional or absent transmembrane domain and consequently to a loss of surface antigen. This irreversible loss of CD19 advocates for an alternative targeting or combination CAR approach.
引用
收藏
页码:1504 / +
页数:5
相关论文
共 22 条
[1]
Buechner J., 2017, EHA, V17
[2]
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples [J].
Cibulskis, Kristian ;
Lawrence, Michael S. ;
Carter, Scott L. ;
Sivachenko, Andrey ;
Jaffe, David ;
Sougnez, Carrie ;
Gabriel, Stacey ;
Meyerson, Matthew ;
Lander, Eric S. ;
Getz, Gad .
NATURE BIOTECHNOLOGY, 2013, 31 (03) :213-219
[3]
A framework for variation discovery and genotyping using next-generation DNA sequencing data [J].
DePristo, Mark A. ;
Banks, Eric ;
Poplin, Ryan ;
Garimella, Kiran V. ;
Maguire, Jared R. ;
Hartl, Christopher ;
Philippakis, Anthony A. ;
del Angel, Guillermo ;
Rivas, Manuel A. ;
Hanna, Matt ;
McKenna, Aaron ;
Fennell, Tim J. ;
Kernytsky, Andrew M. ;
Sivachenko, Andrey Y. ;
Cibulskis, Kristian ;
Gabriel, Stacey B. ;
Altshuler, David ;
Daly, Mark J. .
NATURE GENETICS, 2011, 43 (05) :491-+
[4]
COSMIC: exploring the world's knowledge of somatic mutations in human cancer [J].
Forbes, Simon A. ;
Beare, David ;
Gunasekaran, Prasad ;
Leung, Kenric ;
Bindal, Nidhi ;
Boutselakis, Harry ;
Ding, Minjie ;
Bamford, Sally ;
Cole, Charlotte ;
Ward, Sari ;
Kok, Chai Yin ;
Jia, Mingming ;
De, Tisham ;
Teague, Jon W. ;
Stratton, Michael R. ;
McDermott, Ultan ;
Campbell, Peter J. .
NUCLEIC ACIDS RESEARCH, 2015, 43 (D1) :D805-D811
[5]
Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy [J].
Gardner, Rebecca ;
Wu, David ;
Cherian, Sindhu ;
Fang, Min ;
Hanafi, Laila-Aicha ;
Finney, Olivia ;
Smithers, Hannah ;
Jensen, Michael C. ;
Riddell, Stanley R. ;
Maloney, David G. ;
Turtle, Cameron J. .
BLOOD, 2016, 127 (20) :2406-2410
[6]
T Cells Engineered With a Chimeric Antigen Receptor (CAR) Targeting CD19 (CTL019) Produce Significant In Vivo Proliferation, Complete Responses and Long-Term Persistence Without Gvhd In Children and Adults With Relapsed, Refractory ALL [J].
Grupp, Stephan A. ;
Frey, Noelle V. ;
Aplenc, Richard ;
Barrett, David M. ;
Chew, Anne ;
Kalos, Michael ;
Levine, Bruce L. ;
Litchman, Manuel ;
Maude, Shannon L. ;
Rheingold, Susan R. ;
Shen, Angela ;
Strait, Christine ;
Teachey, David T. ;
Wood, Patricia A. ;
Porter, David ;
June, Carl H. .
BLOOD, 2013, 122 (21)
[7]
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity [J].
Jacoby, Elad ;
Nguyen, Sang M. ;
Fountaine, Thomas J. ;
Welp, Kathryn ;
Gryder, Berkley ;
Qin, Haiying ;
Yang, Yinmeng ;
Chien, Christopher D. ;
Seif, Alix E. ;
Lei, Haiyan ;
Song, Young K. ;
Khan, Javed ;
Lee, Daniel W. ;
Mackall, Crystal L. ;
Gardner, Rebecca A. ;
Jensen, Michael C. ;
Shern, Jack F. ;
Fry, Terry J. .
NATURE COMMUNICATIONS, 2016, 7
[8]
Fast and accurate short read alignment with Burrows-Wheeler transform [J].
Li, Heng ;
Durbin, Richard .
BIOINFORMATICS, 2009, 25 (14) :1754-1760
[9]
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia [J].
Maude, S. L. ;
Laetsch, T. W. ;
Buechner, J. ;
Rives, S. ;
Boyer, M. ;
Bittencourt, H. ;
Bader, P. ;
Verneris, M. R. ;
Stefanski, H. E. ;
Myers, G. D. ;
Qayed, M. ;
De Moerloose, B. ;
Hiramatsu, H. ;
Schlis, K. ;
Davis, K. L. ;
Martin, P. L. ;
Nemecek, E. R. ;
Yanik, G. A. ;
Peters, C. ;
Baruchel, A. ;
Boissel, N. ;
Mechinaud, F. ;
Balduzzi, A. ;
Krueger, J. ;
June, C. H. ;
Levine, B. L. ;
Wood, P. ;
Taran, T. ;
Leung, M. ;
Mueller, K. T. ;
Zhang, Y. ;
Sen, K. ;
Lebwohl, D. ;
Pulsipher, M. A. ;
Grupp, S. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (05) :439-448
[10]
MAUDE SL, 2016, BLOOD, V128